ClinConnect ClinConnect Logo
Search / Trial NCT06795789

Multivitamin Intervention and Cognitive Function

Launched by BRAINCARE LIMITED · Jan 27, 2025

Trial Information

Current as of October 22, 2025

Not yet recruiting

Keywords

Multivitamin Polyphenols Blueberry Cognitive Function Homocysteine B Vitamins Vitamin D

ClinConnect Summary

This clinical trial is looking to understand how a multivitamin combined with blueberry polyphenol (called Vitals+) affects thinking skills in healthy adults. Researchers also want to see how certain nutrients in the body change when people take this supplement. The study is completely remote, meaning you can participate from home without needing to go anywhere in person.

To take part, you need to be a healthy adult over 18 years old, have access to a computer with the internet, and be new to taking nutritional supplements. If you join, you'll complete a fun online game to test your thinking skills and send in a small blood sample to check your nutrient levels. After taking the Vitals+ supplement daily for three months, you’ll repeat the blood test and the game to see how things have changed. It's important to note that people with certain health conditions or who have taken other supplements recently may not be eligible. This study could provide valuable insights into how nutrition impacts cognitive function!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Healthy Men and Women age \>18 years
  • Newly subscribed to the nutritional supplement
  • Access to a PC or laptop with internet connection
  • Exclusion Criteria:
  • Unable to give informed consent
  • Consumed a nutritional supplement in past 3 months
  • Consuming \> 4 portions of B-vitamin fortified foods a week
  • Pregnant or breastfeeding
  • Diagnosis of a neurological condition, such as Dementia, depression or anxiety
  • Prescribed vitamin B12 injections

About Braincare Limited

Braincare Limited is a pioneering clinical trial sponsor dedicated to advancing neurological health through innovative research and development. With a focus on delivering transformative therapies for brain-related disorders, the company employs cutting-edge methodologies and a patient-centered approach to drive clinical excellence. Collaborating with leading researchers and healthcare professionals, Braincare Limited aims to enhance treatment options and improve outcomes for patients suffering from various neurological conditions. Committed to integrity and scientific rigor, the company strives to contribute significantly to the field of neuroscience and to the overall well-being of individuals affected by these challenging disorders.

Locations

London, United Kingdom

Patients applied

0 patients applied

Trial Officials

Harry R Jarrett, Ph.D

Principal Investigator

Heights

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported